The center integrates two essential functions under Pfizer’s export-oriented undertaking.
Chennai:
In a significant move to bring critical research and development capabilities under one roof, pharmaceutical company Pfizer has set up a global drug development center at IIT Madras Research Park in Chennai, Tamil Nadu.
The center’s capabilities will include the development of both active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) of differentiated products such as complex/value-added formulations, controlled-release dosage forms, device-combination products, lyophilized injections, powders, and more. -Fill products, and ready-to-use formulations. It will develop and support products in global markets and Pfizer’s manufacturing centers around the world.
“Pfizer’s Drug Development Center at IIT Madras Research Park is indeed a positive opportunity to establish one of the most advanced laboratories that Pfizer is setting up in Chennai and anywhere in the world for R&D in the above disciplines,” S. Sridhar, Country Manager, Pfizer India.
“We are confident that this will allow the co-development of state-of-the-art API and FDF processes under one roof. The world-class scientific, technology and innovation-driven research park complex provides an ideal setting for our work. We are looking forward to It is hoped that proximity to IIT Madras and other technology research park start-ups will also improve academic and industry partnerships and encourage greater collaboration to drive innovation.”
Pfizer has invested USD 20 million (INR 150 crore) in a 61,000 sq ft research and technology center at IIT Madras Research Park. While the center will be a part of a network of 12 global centers set up around the world, it is currently the first and only one being set up by Pfizer in Asia.
Speaking at the launch, S Aparna, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India said that there is a growing need for pharma companies to provide innovative solutions that address the new challenges faced by healthcare providers and patients. We do.
“This new center by Pfizer in Chennai is a step in that direction. Such efforts to strengthen and expand global work through this center will allow for knowledge sharing that we hope will improve patient outcomes in the years to come. This will also allow Pfizer to take advantage of and showcase the large talent pool in India as well as the best-in-class infrastructure available at the IIT Madras Research Park,” said Aparna.
He said, “We are confident that this research center will be aligned with our larger national objective of improving the availability, affordability and access of medicines from India to the world by building on convergence with the digital solutions available here and leveraging academic collaboration. ” ,
The center integrates two essential functions under Pfizer’s export-oriented undertaking: the Pharmaceutical Sciences (Pharmacy) and the Global Technology and Engineering (GT&E) Center of Excellence.
PharmSci is dedicated to the development of Anti-infectives, Oncolytics, Sterile Injectables, Anesthesia products, CNS products and uniquely differentiated hospital products. GT&E is a leader in next-generation API process and manufacturing technology to supply drugs to patients around the world.
“We are delighted to welcome the Pfizer Global Drug Development Center to the IIT Madras Research Park. We believe that Pfizer’s close proximity to IITM, scientists and students, the Tech Corridor and other leading industry start-ups is the key to industry and industry. will promote greater collaboration between academia. We are also sure that IITM academics will benefit from access to Pfizer’s centre,” said Professor Ashok Jhunjhunwala, President, IITM Research Park.
This 61,000-square-foot facility employs 250 scientists and professionals, including formulation scientists and pharmacists, analytical scientists specializing in process, analytical and formulation pharmacological sciences, life science experts such as microbiologists and biotechnologists, chemical engineers, data scientists, and biotechnologists. and program manager.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)